280 related articles for article (PubMed ID: 25398768)
21. Novel role of TRPV2 in promoting the cytotoxicity of H2O2-mediated oxidative stress in human hepatoma cells.
Ma W; Li C; Yin S; Liu J; Gao C; Lin Z; Huang R; Huang J; Li Z
Free Radic Biol Med; 2015 Dec; 89():1003-13. PubMed ID: 26456053
[TBL] [Abstract][Full Text] [Related]
22. Lysophosphatidic acid receptor 1 antagonist ki16425 blunts abdominal and systemic inflammation in a mouse model of peritoneal sepsis.
Zhao J; Wei J; Weathington N; Jacko AM; Huang H; Tsung A; Zhao Y
Transl Res; 2015 Jul; 166(1):80-8. PubMed ID: 25701366
[TBL] [Abstract][Full Text] [Related]
23. Chrysin enhances sensitivity of BEL-7402/ADM cells to doxorubicin by suppressing PI3K/Akt/Nrf2 and ERK/Nrf2 pathway.
Gao AM; Ke ZP; Shi F; Sun GC; Chen H
Chem Biol Interact; 2013 Oct; 206(1):100-8. PubMed ID: 23994249
[TBL] [Abstract][Full Text] [Related]
24. Methylation-regulated miR-149 modulates chemoresistance by targeting GlcNAc N-deacetylase/N-sulfotransferase-1 in human breast cancer.
He DX; Gu XT; Li YR; Jiang L; Jin J; Ma X
FEBS J; 2014 Oct; 281(20):4718-30. PubMed ID: 25156775
[TBL] [Abstract][Full Text] [Related]
25. LPA1 Mediates Antidepressant-Induced ERK1/2 Signaling and Protection from Oxidative Stress in Glial Cells.
Olianas MC; Dedoni S; Onali P
J Pharmacol Exp Ther; 2016 Nov; 359(2):340-353. PubMed ID: 27605627
[TBL] [Abstract][Full Text] [Related]
26. Co-Eradication of Breast Cancer Cells and Cancer Stem Cells by Cross-Linked Multilamellar Liposomes Enhances Tumor Treatment.
Kim YJ; Liu Y; Li S; Rohrs J; Zhang R; Zhang X; Wang P
Mol Pharm; 2015 Aug; 12(8):2811-22. PubMed ID: 26098197
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of autotaxin delays breast tumor growth and lung metastasis in mice.
Benesch MG; Tang X; Maeda T; Ohhata A; Zhao YY; Kok BP; Dewald J; Hitt M; Curtis JM; McMullen TP; Brindley DN
FASEB J; 2014 Jun; 28(6):2655-66. PubMed ID: 24599971
[TBL] [Abstract][Full Text] [Related]
28. Reversal of multidrug resistance by two nordihydroguaiaretic acid derivatives, M4N and maltose-M3N, and their use in combination with doxorubicin or paclitaxel.
Chang CC; Liang YC; Klutz A; Hsu CI; Lin CF; Mold DE; Chou TC; Lee YC; Huang RC
Cancer Chemother Pharmacol; 2006 Nov; 58(5):640-53. PubMed ID: 16544145
[TBL] [Abstract][Full Text] [Related]
29. Synthesis of piperlongumine analogues and discovery of nuclear factor erythroid 2-related factor 2 (Nrf2) activators as potential neuroprotective agents.
Peng S; Zhang B; Meng X; Yao J; Fang J
J Med Chem; 2015 Jul; 58(13):5242-55. PubMed ID: 26079183
[TBL] [Abstract][Full Text] [Related]
30. Role of lysophosphatidic acid receptor LPA2 in the development of allergic airway inflammation in a murine model of asthma.
Zhao Y; Tong J; He D; Pendyala S; Evgeny B; Chun J; Sperling AI; Natarajan V
Respir Res; 2009 Nov; 10(1):114. PubMed ID: 19930563
[TBL] [Abstract][Full Text] [Related]
31. Moderate increase in Mdr1a/1b expression causes in vivo resistance to doxorubicin in a mouse model for hereditary breast cancer.
Pajic M; Iyer JK; Kersbergen A; van der Burg E; Nygren AO; Jonkers J; Borst P; Rottenberg S
Cancer Res; 2009 Aug; 69(16):6396-404. PubMed ID: 19654309
[TBL] [Abstract][Full Text] [Related]
32. Implications for breast cancer treatment from increased autotaxin production in adipose tissue after radiotherapy.
Meng G; Tang X; Yang Z; Benesch MGK; Marshall A; Murray D; Hemmings DG; Wuest F; McMullen TPW; Brindley DN
FASEB J; 2017 Sep; 31(9):4064-4077. PubMed ID: 28539367
[TBL] [Abstract][Full Text] [Related]
33. B4GALT1 gene knockdown inhibits the hedgehog pathway and reverses multidrug resistance in the human leukemia K562/adriamycin-resistant cell line.
Zhou H; Zhang Z; Liu C; Jin C; Zhang J; Miao X; Jia L
IUBMB Life; 2012 Nov; 64(11):889-900. PubMed ID: 23024026
[TBL] [Abstract][Full Text] [Related]
34. HER2 confers drug resistance of human breast cancer cells through activation of NRF2 by direct interaction.
Kang HJ; Yi YW; Hong YB; Kim HJ; Jang YJ; Seong YS; Bae I
Sci Rep; 2014 Dec; 4():7201. PubMed ID: 25467193
[TBL] [Abstract][Full Text] [Related]
35. LPA receptor1 antagonists as anticancer agents suppress human lung tumours.
Zhao PF; Wu S; Li Y; Bao G; Pei JY; Wang YW; Ma Q; Sun HJ; Damirin A
Eur J Pharmacol; 2020 Feb; 868():172886. PubMed ID: 31866407
[TBL] [Abstract][Full Text] [Related]
36. Role of the autotaxin-lysophosphatidate axis in the development of resistance to cancer therapy.
Tang X; Benesch MGK; Brindley DN
Biochim Biophys Acta Mol Cell Biol Lipids; 2020 Aug; 1865(8):158716. PubMed ID: 32305571
[TBL] [Abstract][Full Text] [Related]
37. Proliferation of mouse endometrial stromal cells in culture is highly sensitive to lysophosphatidic acid signaling.
Aikawa S; Kano K; Inoue A; Aoki J
Biochem Biophys Res Commun; 2017 Feb; 484(1):202-208. PubMed ID: 28073697
[TBL] [Abstract][Full Text] [Related]
38. Putative chemopreventive molecules can increase Nrf2-regulated cell defense in some human cancer cell lines, resulting in resistance to common cytotoxic therapies.
Hu L; Miao W; Loignon M; Kandouz M; Batist G
Cancer Chemother Pharmacol; 2010 Aug; 66(3):467-74. PubMed ID: 19940992
[TBL] [Abstract][Full Text] [Related]
39. Glycycoumarin ameliorates alcohol-induced hepatotoxicity via activation of Nrf2 and autophagy.
Song X; Yin S; Huo Y; Liang M; Fan L; Ye M; Hu H
Free Radic Biol Med; 2015 Dec; 89():135-46. PubMed ID: 26169726
[TBL] [Abstract][Full Text] [Related]
40. Lysophosphatidic acid receptor-2 (LPA
Minami K; Ueda N; Ishimoto K; Tsujiuchi T
Mol Cell Biochem; 2020 Jun; 469(1-2):89-95. PubMed ID: 32301060
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
